Delivery Order SPE2DB20D1004-SPE2DB21FF1E6
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (Order) under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999. The Order, worth $10,791.02, is for a Prime Vendor Pharmaceutical contract to supply a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and medical devices, to...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is for a prime vendor pharmaceutical contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,081.81, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 through November 2026. The prime vendor contract covers the delivery of a comprehensive range of pharmaceutical products and medical supplies,...
- This federal contract award is for a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The Delivery Order, valued at $6,111.66, is for a "PRIME VENDOR PHARM BRANCH-PHILADELPHIA" and covers the supply of a range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and...
- The federal contract award is for a Delivery Order with a Firm Fixed Price contract type, valued at $2,553.53, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for a "PRIME VENDOR PHARM BRANCH-PHILADELPHIA" and covers the delivery of a range of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, medical devices, syringes, and other critical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to serve as a prime vendor for pharmaceutical products and medical supplies. The contract, valued at $2,677.42, is a delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical worth up to $999,999,999.00. This IDC, which runs through November 2026, enables Amerisourcebergen to efficiently deliver a comprehensive range...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order, valued at $6,833.82, is for "PRIME...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $2,916.35 for "Prime Vendor Pharm Branch-Philadelphia" under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,314.32 for "PRIME VENDOR PHARM BRANCH-PHILADELPHIA" under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The award has no set-aside designation, indicating open competition. The contract covers the delivery of a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order worth $10,060.56 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The IDC, valued at up to $999,999,999.00, provides a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. This specific Delivery Order is for a...
- This federal contract award is for a pharmaceutical prime vendor contract issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $13,717.03, is a delivery order awarded under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The contract provides for the delivery of a comprehensive...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB21FF1E6Delivery Order
This federal contract award is for a Delivery Order valued at $2,757.44, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract is for a "PRIME VENDOR PHARM BRANCH-PHILADELPHIA" to provide a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The award did not have a set-aside designation, indicating full and open competition. This IDC serves as a primary vehicle for Amerisourcebergen to efficiently deliver essential pharmaceutical and medical commodities to the Department of Defense and other government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 1/27/21 |